Oncology
Bradley Hunter, MD, MPH
Director of Immune Effector Cell Therapy; Interim Medical Director of Oncology Research; Assistant Professor
Dr. Bradley Hunter, MD, MPH, is a medical oncologist specializing in hematologic malignancies at Intermountain Healthcare in Salt Lake City, Utah. He serves as Director of Immune Effector Cell Therapy and Interim Medical Director of Oncology Research, while also functioning as an Assistant Professor and member of the Bone Marrow Transplant team at LDS Hospital. His clinical expertise centers on bone marrow transplantation, CAR T-cell therapy, immune effector cell therapy, and stem cell transplan
12+
Years in Practice
Credentials
Board Certifications
- Medical Oncology
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute — Fellowship, Hematology and Medical Oncology, 2017 - 2019
- University of California (San Francisco) — Residency, Internal Medicine, 2014 - 2017
- University of Rochester School of Medicine and Dentistry — M.D., Class of 2014
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- LDS Hospital
- Intermountain Medical Center
- Alta View Hospital
- Intermountain Healthcare
Languages
English
Experience
12+ years in practice